Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-26

Clinical Trial Update: Inorganic Nitrite to Amplify the Benefits and Tolerability of Exercise Training in Heart Failure With Preserved Ejection Fraction (HFpEF) (INABLE-Training) [Phase 2]

View source ↗

Summary

Phase 2 trial updating the use of inorganic nitrite to enhance exercise training in heart failure with preserved ejection fraction (HFpEF).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Barry Borlaug | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2023-04-26